Redmile Group as of Dec. 31, 2023
Portfolio Holdings for Redmile Group
Redmile Group holds 70 positions in its portfolio as reported in the December 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
ImmunoGen | 17.4 | $487M | 16M | 29.65 | |
Krystal Biotech (KRYS) | 7.7 | $215M | 1.7M | 124.06 | |
Amicus Therapeutics (FOLD) | 7.5 | $210M | 15M | 14.19 | |
Scholar Rock Hldg Corp (SRRK) | 4.3 | $120M | 6.4M | 18.80 | |
Rayzebio | 4.1 | $116M | 1.9M | 62.17 | |
Augmedix (AUGX) | 3.4 | $96M | 16M | 5.85 | |
Deciphera Pharmaceuticals | 2.8 | $77M | 4.8M | 16.13 | |
Spdr S&p 500 Etf Tr Tr Unit (SPY) | 2.4 | $68M | 143k | 475.31 | |
Regenxbio Inc equity us cm (RGNX) | 2.4 | $68M | 3.8M | 17.95 | |
Biohaven (BHVN) | 2.2 | $62M | 1.4M | 42.80 | |
Zymeworks Del (ZYME) | 2.2 | $60M | 5.8M | 10.39 | |
Livanova SHS (LIVN) | 2.1 | $59M | 1.1M | 51.74 | |
Alx Oncology Hldgs (ALXO) | 1.9 | $55M | 3.7M | 14.89 | |
Catalent (CTLT) | 1.8 | $49M | 1.1M | 44.93 | |
Fate Therapeutics (FATE) | 1.8 | $49M | 13M | 3.74 | |
Pliant Therapeutics (PLRX) | 1.7 | $49M | 2.7M | 18.11 | |
Kymera Therapeutics (KYMR) | 1.7 | $46M | 1.8M | 25.46 | |
Immunome (IMNM) | 1.5 | $42M | 3.9M | 10.70 | |
Immunovant (IMVT) | 1.5 | $41M | 977k | 42.13 | |
Boston Scientific Corporation (BSX) | 1.4 | $40M | 693k | 57.81 | |
Shattuck Labs (STTK) | 1.4 | $40M | 5.6M | 7.13 | |
Celldex Therapeutics Com New (CLDX) | 1.4 | $39M | 994k | 39.66 | |
Beam Therapeutics (BEAM) | 1.4 | $39M | 1.4M | 27.22 | |
Absci Corp (ABSI) | 1.2 | $34M | 8.0M | 4.20 | |
Nurix Therapeutics (NRIX) | 1.2 | $34M | 3.3M | 10.32 | |
Ideaya Biosciences (IDYA) | 1.2 | $33M | 936k | 35.58 | |
Replimune Group (REPL) | 1.2 | $33M | 3.9M | 8.43 | |
Cabaletta Bio (CABA) | 1.1 | $31M | 1.4M | 22.70 | |
Abbott Laboratories (ABT) | 1.0 | $29M | 266k | 110.07 | |
Evolent Health Cl A (EVH) | 1.0 | $28M | 836k | 33.03 | |
Akero Therapeutics (AKRO) | 0.9 | $26M | 1.1M | 23.35 | |
Adc Therapeutics Sa SHS (ADCT) | 0.9 | $25M | 15M | 1.66 | |
Annexon (ANNX) | 0.9 | $25M | 5.5M | 4.54 | |
Igm Biosciences (IGMS) | 0.9 | $25M | 3.0M | 8.31 | |
Verve Therapeutics (VERV) | 0.9 | $24M | 1.7M | 13.94 | |
Penumbra (PEN) | 0.9 | $24M | 95k | 251.54 | |
89bio (ETNB) | 0.8 | $22M | 2.0M | 11.17 | |
Charles River Laboratories (CRL) | 0.7 | $21M | 87k | 236.40 | |
Entrada Therapeutics (TRDA) | 0.7 | $19M | 1.3M | 15.09 | |
Neurogene (NGNE) | 0.7 | $18M | 947k | 19.38 | |
Intuitive Surgical Com New (ISRG) | 0.7 | $18M | 54k | 337.36 | |
Hca Holdings (HCA) | 0.6 | $18M | 66k | 270.68 | |
Cogent Biosciences (COGT) | 0.6 | $17M | 2.9M | 5.88 | |
Stryker Corporation (SYK) | 0.6 | $16M | 53k | 299.46 | |
Repare Therapeutics Ord (RPTX) | 0.6 | $16M | 2.1M | 7.30 | |
Stoke Therapeutics (STOK) | 0.5 | $14M | 2.6M | 5.26 | |
Align Technology (ALGN) | 0.5 | $14M | 50k | 274.00 | |
Gritstone Oncology Ord (GRTS) | 0.4 | $12M | 5.9M | 2.04 | |
Prime Medicine (PRME) | 0.4 | $12M | 1.3M | 8.86 | |
Anthem (ELV) | 0.4 | $11M | 23k | 471.56 | |
Allakos (ALLK) | 0.4 | $10M | 3.7M | 2.73 | |
Ac Immune Sa SHS (ACIU) | 0.4 | $10M | 2.0M | 5.00 | |
Rapt Therapeutics (RAPT) | 0.3 | $9.1M | 367k | 24.85 | |
Stereotaxis Com New (STXS) | 0.2 | $6.0M | 3.4M | 1.75 | |
Adagio Therapeutics (IVVD) | 0.2 | $5.7M | 1.4M | 3.94 | |
Science 37 Holdings Com New | 0.2 | $5.3M | 990k | 5.34 | |
Atara Biotherapeutics | 0.2 | $4.7M | 9.1M | 0.51 | |
Nuvation Bio Com Cl A (NUVB) | 0.2 | $4.6M | 3.0M | 1.51 | |
Lava Therapeutics Nv SHS (LVTX) | 0.1 | $3.3M | 2.1M | 1.58 | |
Medavail Holdings Com New (MDVLQ) | 0.1 | $3.1M | 692k | 4.41 | |
Xeris Pharmaceuticals (XERS) | 0.1 | $2.5M | 1.0M | 2.35 | |
Achilles Therapeutics Sponsored Ads (ACHL) | 0.1 | $1.4M | 1.6M | 0.89 | |
Allovir (ALVR) | 0.0 | $1.3M | 1.9M | 0.68 | |
Somalogic Class A Com | 0.0 | $938k | 371k | 2.53 | |
Invitae (NVTAQ) | 0.0 | $924k | 1.5M | 0.63 | |
Hookipa Pharma Inc equity | 0.0 | $862k | 1.1M | 0.81 | |
Alpha Teknova (TKNO) | 0.0 | $601k | 161k | 3.73 | |
Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.0 | $568k | 716k | 0.79 | |
Ventyx Biosciences (VTYX) | 0.0 | $512k | 207k | 2.47 | |
Atreca Cl A Com (BCEL) | 0.0 | $58k | 443k | 0.13 |